Navigation Links
Charles Drew University researcher will be honored for discoveries
Date:3/25/2010

Dr. Mamdooh Ghoneum today will discuss his findings on cancer research and treatment at the Egyptian Embassy in Washington, D.C.

The event, sponsored by the Egyptian Cultural and Educational Bureau, will run from 6 p.m. to 8 p.m., followed by a reception.

Ghoneum, an Egyptian-born researcher and professor at Charles Drew University of Medicine and Science in Los Angeles, has been studying natural cures for cancer for more than two decades. His research has centered on a critical theory: That cancer cells, when exposed to small amounts of yeast, have died.

"I have no doubt that I am close to unlocking the mystery as to why cancer cells weaken to the point of destruction after eating common baker's yeast," Dr. Ghoneum said earlier this year. "The cells just gravitate to the yeast. I call it fatal attraction."

His recent experiments have shown that yeast created significant clearance when cancer cells metasized to lungs in mice. His research in previous years has shown that tumors in mice decreased in size when injected with yeast. Lately, Dr. Ghoneum has focused on figuring out how much yeast can be considered a safe and effective dosage.

His research has been reproduced by scientists worldwide, with results published in leading medical journals. The immunologist's research also has been affirmed at the U.S. Department of Health and Science, National Institute of Health.

Dr. Ghoneum earned his Ph.D at the University of Tokyo in 1980 and completed his postdoctoral studies at UCLA.

Reservations for today's event can be made at the embassy, located at 3521 International Court N.W. in Washington, by calling 202-296-3959 or by sending an email to eecous@eecous.net.


'/>"/>

Contact: Daryl Strickland
darylstrickland@live.com
562-229-4924
Charles Drew University of Medicine and Science
Source:Eurekalert

Page: 1

Related biology news :

1. The surprising story of Charles Darwin and his homeopathic doctor
2. TSC honors Sen. Charles Schumer
3. GEN joins Charles Darwin 2009 celebration
4. Pest management specialist Charles Summers wins prestigious Woodworth Award
5. Why do we choose our mates? Ask Charles Darwin, prof says
6. 2009 Charles River Laboratories Excellence in Refinement Award
7. Charles Drew cancer studies with yeast yield excellent results
8. Charles Darwin really did have advanced ideas about the origin of life
9. Charles Darwin and modern biology
10. Charles Darwin: More than the origin
11. Charles Drew University, UC Irvine awarded $480,000 grant for research low birth weight infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... , Feb. 8, 2017 About Voice Recognition ... to match it against a stored voiceprint template. ... pitch, cadence, and tone are compared to distinguish ... hardware installation, as most PCs already have a ... transactions. Voice recognition biometrics are most likely to ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... Feb. 28, 2017  ITL Limited ( ASX:ITD ... and strategic partner that provides innovative products and ... management, formally announces its rebrand to ITL Health ... is part of the Company,s unified global rebranding ... an integrated corporate website, ITLHealthGroup.com . ITL,s ...
(Date:2/27/2017)... (PRWEB) , ... February 27, ... ... award-winning high-pressure pasteurized cold-pressed fruit and vegetable drink brand is now available ... Michigan-based Vegesentials USA, LLC to manufacture and distribute the Vegesentials line of ...
(Date:2/27/2017)... and HAMILTON, Bermuda , ... (NASDAQ: ADXS ) and SELLAS ... focused on developing cancer immunotherapies, today announced that ... a novel cancer immunotherapy agent using Advaxis, proprietary ... patented WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/25/2017)... Garden City, New York (PRWEB) , ... February ... ... announced their partnership with Verified Clinical Trials in an ongoing effort ... the areas of treatment, advocacy, and pharmaceutical research with emphasis on consumers and ...
Breaking Biology Technology: